PMV Pharmaceuticals, Inc.PMVP
Price (close)
$1.33
Market cap
$71.4M
P/E
—
Revenue (TTM)
—
Net income
-$75.2M
Dividend yield
—
1-year total return
-4.6%
Net margin
—
Revenue growth
—
Debt / equity
—
What PMV Pharmaceuticals, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$34.4M | -$57.8M | -$73.3M | -$69.0M | -$58.7M | -$77.7M |
| Free cash flow | -$32.9M | -$47.9M | -$71.7M | -$56.6M | -$51.9M | -$73.6M |
More on PMVP.
- PMV Pharmaceuticals, Inc. summary
- PMV Pharmaceuticals, Inc. financial statements
- PMV Pharmaceuticals, Inc. key metrics
- PMV Pharmaceuticals, Inc. health scores and style box
- PMV Pharmaceuticals, Inc. earnings
- PMV Pharmaceuticals, Inc. dividends
- PMV Pharmaceuticals, Inc. valuation
- PMV Pharmaceuticals, Inc. ownership and insiders
- PMV Pharmaceuticals, Inc. peers
Figures from PMV Pharmaceuticals, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.